The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
Maven Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FSE: TLAA) owns ‘Maven Cannabis Inc’, a Licensed Producer of cannabis with a 19,500 square foot facility located on a 37 acre industrial site, centrally located in the Village of Lumby, British Columbia. Learn more at www.mavenbrands.ca.
MindBio is a leading biotech/biopharma company focused on creating novel and emerging treatments for mental health conditions and is conducting world first take-home Microdosing (MB22001) human clinical trials. MB22001 is MindBio’s lead candidate drug, a proprietary titratable form of Lysergic Acid Diethylamide (LSD) designed for take-home microdosing. MindBio is a leader in microdosing of psychedelic medicines and is advancing its drug and technology protocols through clinical trials. MindBio has developed a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase 1 clinical trials in 80 healthy participants, has a Phase 2a clinical trial just completed microdosing in patients with Major Depressive Disorder and a Phase 2B clinical trial currently underway microdosing in late stage cancer patients experiencing existential distress. The Company has also started dosing in a Phase 2B Depression Trial. MindBio invests in research that forms the basis for developing novel and clinically proven treatments including digital technologies and interventions to treat debilitating health conditions such as depression, anxiety and other related mental health conditions.
Molecule works with client-partners to engage in the production of cannabis-infused beverages and edibles. We provide the infrastructure, know-how, technology, and licenses for craft producers to create consumable cannabis products. Molecule’s goal is to be the on-ramp for companies wishing to enter into the cannabis beverage and edibles market, but who choose not to go through the significant process of obtaining the required cannabis licences.
Mountain Valley MD Holdings Inc., through its subsidiary Mountain Valley MD Inc. (“MVMD”) is building a health and wellness organization centred around the implementation of patented oral delivery technologies to create industry leading products that are sought out globally. MVMD’s proposition for delivering formulations that have rapid onset, with high bioavailability, with precision dosing technology, will be core to our success across key health and wellness categories.
MTL Cannabis is the parent company of Montréal Medical Cannabis Inc., a licensed producer headquartered in Montréal, Québec and operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., with clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions.
Mynd is a life sciences based neuro-pharmaceutical drug development company advancing medicines that leverage psychedelic compounds. Our mission is to further our existing research and patents linking depression and inflammation at the genetic and cellular level to develop pharmaceutical treatments.
MyndTec is a Canadian medical technology company dedicated to the development and commercialization of innovative products that improve function, maximize independence and enhance the quality of life for individuals who have suffered injury to the central nervous system as a result of stroke, spinal cord injury and certain traumatic brain injuries.
NanoSphere Health Sciences is a biotechnology company that has developed and is commercializing its patented NanoSphere Delivery System™, a ground breaking platform using nanotechnology for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. The NanoSphere Delivery System™ provides improved bioavailability, efficacy and onset of effect over traditional delivery systems, and represents one of the most important developments for advancing the non-invasive and user-friendly delivery of biological agents in over 25 years. Under the brand name “Evolve”, NanoSphere has already launched its acclaimed NanoSerum™ product for the recreational and medical cannabis markets in Colorado, and will build on that success by opening new markets for Evolve and developing and commercializing new applications for NanoSerum™.
nDatalyze Corp. generates technology-based, health-related solutions. Investors are encouraged to contact the Corporation by email at jimd@ndatalyze.com or by telephone at (403) 689-3901.
